Full Text View
Tabular View
No Study Results Posted
Related Studies
Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib
This study has been completed.
Study NCT00365313   Information provided by Chinese University of Hong Kong
First Received: August 16, 2006   Last Updated: October 26, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arthritis
Bleeding Ulcer
Additional conditions recognized in this trial
Hemorrhage
Ulcer
More general conditions related to this trial
Joint Diseases
Musculoskeletal Diseases
Pathologic Processes
Interventions listed in this trial
celecoxib, esomeprazole
Additional drug interventions recognized in this trial
Celecoxib
Omeprazole
Proton Pump Inhibitors
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Anti-Ulcer Agents
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Chinese University of Hong Kong


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services